Gregg W. Stone, MD

New York, New York

Gregg W. Stone, MD

Interventional Cardiologist

About

Dr. Gregg W. Stone is Dr Stone is the director of Academic Affairs for Mount Sinai Heart Health System and professor of Medicine and Population Health Sciences and Policy at The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine. Dr Stone is a leading expert in interventional cardiology and is one of the most widely cited researchers in science. He has served as the principal investigator for approximately 130 national and international multicentre randomised trials, has delivered thousands of lectures internationally, and has authored more than 2,500 book chapters, manuscripts and abstracts published in peer-reviewed literature.

Dr. Stone’s areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents; antiplatelet and antithrombotic pharmacotherapies; transcatheter mitral valve repair and replacement; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, vascular brachytherapy, and stent grafts; saphenous vein graft therapies; intravascular imaging; chronic total occlusions; left atrial appendage closure; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone’s medical practice is devoted to interventional cardiology at New York-Presbyterian Hospital and Columbia University Medical Center

Education and Training

  • General Cardiology and Advanced Coronary Angioplasty Fellowships, Cedars-Sinai Medical Center - Mid-America Heart Institute, 1988
  • Residency, New York Presbyterian Hospital - New York Weill Cornell Medical Center, 1985
  • Internal Medicine Internship, New York Presbyterian Hospital - New York Weill Cornell Medical Center, 1983
  • Medical Degree, Johns Hopkins University School of Medicine, 1982

Professional Highlights

  • Director, National Interventional Cardiology Fellow's Course
  • Co-Director: Medical Research and Education; Cardiovascular Research Foundation; Transcatheter Cardiovascular Therapeutics; Optimizing Complex PCI Outcomes; The Left Main and Chronic Total Occlusion Summit; Bioresorbable Scaffolds: A Breakthrough PCI Technology; LAA Occlusion: A Technique Oriented Course; and Transcatheter Valve Therapies

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.